VKTX Stock Jumps on 22% Weight Loss Win, But Investors Fear Durability Could Crush Gains
Viking Therapeutics reported 22% weight loss with VK2735 at week 33 versus placebo with no plateau. VKTX stock saw muted gains as investors weigh strong...
Enter code for secure login, or use password.
